See All Slides - tctmd.com

Slides

Presentation TCT 2013

Potential for Rivaroxaban Use in ACS and in the PCI Patient: Why Different Interpretations of the Same Data in the US and Europe?

Presenter: C. Michael Gibson

October 31, 2013

Presentation TCT 2013

DCB and BMS Interaction: A Critical Look at the Data

Presenter: Francesco Liistro

October 31, 2013

Presentation TCT 2013

HYBRID: A Prospective, Randomized Trial of Hybrid Coronary Revascularization vs. Standard Surgical Revascularization in Multivessel Disease

Presenter: Michal Hawranek

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient with a Mechanical Aortic Valve with Bleeding on Warfarin

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

Comparative Features and Performance of Today's and Tomorrow's TAVR Devices

Presenter: Eberhard Grube

October 31, 2013

Presentation TCT 2013

Case 2: How to Overlap Bioresorbable Scaffolds

Presenter: Jose Costa Jr

October 31, 2013

Presentation TCT 2013

How Would I Treat this Patient?(13)

Presenter: Branko Beleslin

October 31, 2013

Presentation TCT 2013

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Presenter: Stephan Windecker

October 31, 2013

Presentation TCT 2013

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

Is Intraprocedural TEE During TAVR a Luxury or a Necessity?

Presenter: Rebecca Hahn

October 31, 2013

Advertisement

Slides

Potential for Rivaroxaban Use in ACS and in the PCI Patient: Why Different Interpretations of the Same Data in the US and Europe?

DCB and BMS Interaction: A Critical Look at the Data

HYBRID: A Prospective, Randomized Trial of Hybrid Coronary Revascularization vs. Standard Surgical Revascularization in Multivessel Disease

Case Presentation: A Patient with a Mechanical Aortic Valve with Bleeding on Warfarin

Comparative Features and Performance of Today's and Tomorrow's TAVR Devices

Case 2: How to Overlap Bioresorbable Scaffolds

How Would I Treat this Patient?(13)

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Is Intraprocedural TEE During TAVR a Luxury or a Necessity?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content